Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia

27Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

This retrospective study assessed the long-term effect of transfusional exchange therapy on MRA/MRI abnormalities in 24 homozygous sickle-cell anemia (HbSS) children presenting with abnormal brain MRA. The median time elapsed from baseline to last available MRA was 29 months. Follow-up MRAs showed improvement, stabilization or worsening of cerebrovascular lesions in 11, 6 and 7 patients respectively. Complete normalization of MRA was observed in 6 patients within a mean time of 1.4 years, but stenosis recurred at the same location in the 4 patients in whom transfusion therapy was discontinued. Baseline severe stenosis/occlusion of large cerebral arteries and occurrence of moyamoya syndrome were significantly associated with an absence of improvement of the cerebral vasculopathy. These data emphasize the heterogeneity of the course of cerebrovasculopathy in SS children receiving chronic transfusion. Further studies are needed to determine whether different therapeutic approaches have to be considered according to these different evolutive patterns in SS children. ©2009 Ferrata Storti Foundation.

Cite

CITATION STYLE

APA

Bader-Meunier, B., Verlhac, S., Elmaleh-Bergès, M., Ithier, G., Sellami, F., Faid, S., … Benkerrou, M. (2009). Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica, 94(1), 123–126. https://doi.org/10.3324/haematol.13610

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free